Lakeland Industries (LAKE) Expected to Announce Quarterly Earnings on Wednesday

Lakeland Industries (NASDAQ:LAKE) is expected to release its Q4 2026 results after the market closes on Wednesday, April 8th. Analysts expect Lakeland Industries to post earnings of ($0.11) per share and revenue of $49.6690 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q4 2026 earning overview page for the latest details on the call scheduled for Thursday, April 16, 2026 at 4:00 PM ET.

Lakeland Industries Stock Performance

NASDAQ:LAKE opened at $8.19 on Wednesday. The company has a market cap of $80.31 million, a price-to-earnings ratio of -1.87 and a beta of 1.29. Lakeland Industries has a fifty-two week low of $7.15 and a fifty-two week high of $20.83. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.48 and a current ratio of 3.83. The stock has a fifty day moving average price of $9.01 and a 200-day moving average price of $11.82.

Hedge Funds Weigh In On Lakeland Industries

Several large investors have recently bought and sold shares of the company. Kennedy Capital Management LLC acquired a new position in shares of Lakeland Industries during the third quarter worth $2,287,000. Geode Capital Management LLC increased its holdings in Lakeland Industries by 115.9% in the second quarter. Geode Capital Management LLC now owns 217,786 shares of the medical instruments supplier’s stock valued at $2,964,000 after purchasing an additional 116,901 shares during the period. UBS Group AG raised its position in Lakeland Industries by 818.1% during the 3rd quarter. UBS Group AG now owns 62,595 shares of the medical instruments supplier’s stock worth $926,000 after purchasing an additional 55,777 shares during the last quarter. LPL Financial LLC bought a new position in Lakeland Industries during the 4th quarter worth $406,000. Finally, Marshall Wace LLP lifted its holdings in Lakeland Industries by 419.4% during the 2nd quarter. Marshall Wace LLP now owns 56,700 shares of the medical instruments supplier’s stock worth $772,000 after buying an additional 45,783 shares during the period. 71.69% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently commented on LAKE. Roth Mkm dropped their price target on Lakeland Industries from $27.00 to $19.00 and set a “buy” rating for the company in a research note on Wednesday, December 10th. Lake Street Capital reduced their price objective on shares of Lakeland Industries from $26.00 to $19.00 and set a “buy” rating on the stock in a research note on Wednesday, December 10th. Wall Street Zen lowered shares of Lakeland Industries from a “hold” rating to a “strong sell” rating in a report on Saturday, December 13th. DA Davidson restated a “neutral” rating and issued a $14.00 target price (down from $20.00) on shares of Lakeland Industries in a research report on Wednesday, December 10th. Finally, UBS Group set a $14.00 price target on shares of Lakeland Industries in a report on Wednesday, December 10th. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $16.50.

More Lakeland Industries News

Here are the key news stories impacting Lakeland Industries this week:

• Positive Sentiment: Lakeland Fire + Safety completed the sale of its High Performance Flame Resistant (HPFR) and High-Visibility (HiViz) product lines to National Safety Apparel. Management says the divestiture strengthens the balance sheet, improves capital flexibility and sharpens focus on fire services growth and core industrial PPE — a near‑term liquidity/strategic positive that can offset some concerns about recent operational mix. Article Title
• Neutral Sentiment: Multiple plaintiff law firms (Rosen, Faruqi & Faruqi, Gross, Bragar, Glancy Prongay Wolke & Rotter, Portnoy, etc.) have issued investor alerts reminding shareholders of an April 24, 2026 deadline to seek lead‑plaintiff status in a securities matter covering purchases from Dec. 1, 2023 to Dec. 9, 2025. These notices are informational and common in contested securities matters but increase public awareness and potential claimant coordination. Article Title
• Negative Sentiment: Pomerantz LLP has filed a formal class action in the Southern District of New York against Lakeland and certain officers alleging violations of Sections 10(b) and 20(a) and seeking damages for the same Dec. 1, 2023–Dec. 9, 2025 class period. A filed federal suit represents an escalation versus mere notices — it can lead to discovery, potential settlements or judgments, legal costs and executive distraction, all of which pose downside risk to shareholders. Article Title

About Lakeland Industries

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.